Anavex Life Sciences Corp.(www.anavex.com) is a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodevelopmental and neurodegenerative diseases.   Anavex is currently in a Phase 2a trial for Alzhei...

Biotechnology

Anavex Life Sciences

Anavex Life Sciences' headquarters in New York, NY, United States

Christopher Missling

Edward Hammond MD, PHD, MPH

Daniel Klamer, PhD, MBA

Daniel Klamer

Alani Selvey

Stephan Toutain

Walter E Kaufmann

Emmanuel O Fadiran

John Harrison

Jacqueline French

Jeffrey Cummings

Norman Relkin

Andrew J. Cole

Corinne Lasmézas

Dag Aarsland

Claus Van Der Velden

Steffen Thomas

Elliot Favus

Peter Donhauser

Tom Skarpelos

Ottavio Arancio

Paul Aisen

Daniel Weintraub

Tangui Nicolas Maurice

The Medical and Scientific Advisory team at Anavex Life Sciences provides expert guidance on the development and clinical strategy of therapeutics targeting neurodevelopmental and neurodegenerative diseases. Through collaboration and collaboration with cross-functional teams, they ensure that scientific rigor is applied to research initiatives, facilitate clinical trial design, and offer insights that enhance the understanding of drug mechanisms and patient outcomes. Their expertise is crucial for advancing Anavex's pipeline and achieving regulatory milestones.

Medical and Scientific Advisory

The Regulatory Affairs and Strategy team at Anavex Life Sciences plays a crucial role in guiding the development of therapeutics through regulatory processes, ensuring compliance with health authority requirements. This team is responsible for strategizing submission plans, managing interactions with regulatory agencies, and providing insights to align clinical development goals with regulatory expectations, thereby facilitating the advancement of innovative treatments for neurodevelopmental and neurodegenerative diseases.

Regulatory Affairs and Strategy

The Clinical Operations and Research team at Anavex Life Sciences is responsible for designing, implementing, and managing clinical trials for the company's innovative therapeutics targeting neurodevelopmental and neurodegenerative diseases. This team ensures compliance with regulatory standards, coordinates multifaceted project operations, and collaborates across departments to gather and analyze clinical data, ultimately contributing to the advancement of treatments for conditions like Alzheimer’s disease.

Clinical Operations and Research

The Leadership Team at Anavex Life Sciences is responsible for setting the strategic direction of the company, overseeing clinical development, regulatory compliance, and operational efficiency. This team, comprising key executives with expertise in business development, regulatory affairs, and medical strategy, drives the advancement of innovative therapeutics for neurodevelopmental and neurodegenerative diseases, ensuring alignment with the company's mission and objectives.

Leadership Team

Anavex Life Sciences

Org chart

Board & advisors

Teams

Medical and Scientific Advisory

Regulatory Affairs and Strategy

Clinical Operations and Research

Leadership Team

Offices

Anavex Life Sciences

Org chart

Board & advisors

Teams

Medical and Scientific Advisory

Regulatory Affairs and Strategy

Clinical Operations and Research

Leadership Team

Offices

Related companies